focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Sleep Sciences Ltd launches 'SleepHub™'

23 Oct 2020 07:00

RNS Number : 9734C
Barkby Group PLC (The)
23 October 2020
 

23 October 2020

 

 

The Barkby Group PLC

 

("Barkby" or the "Company")

 

Cambridge Sleep Sciences Ltd launches 'SleepHub™' - A device to help restore natural sleep

 

Further to the acquisition of the IP of Cambridge Sound Technologies UK Ltd in April 2020 and in line with our business plan to launch a product in the second half of 2020, Barkby, the diversified business group, is pleased to announce that its subsidiary Cambridge Sleep Sciences Ltd has launched its brand-new product, SleepHub™, a device which improves and facilitates natural sleep.

 

SleepHub™is designed to help restore natural sleep cycles and improve wellbeing by using rhythms and pulses to emulate brain waves produced during sleep.

 

The product will retail at £599 per unit in the UK and is now available online at sleephub.com, and through selected partners. Sleep technology is an increasing area of focus and a growth area in the wider holistic wellness space which Cambridge Sleep Sciences Ltd is aiming to be at the forefront of.

 

Cambridge Sleep Sciences Ltd is in advanced discussions with a number of major retailers who are interested in stocking the product and we will update shareholders on progress in due course.

 

Charles Dickson, Executive Chairman of The Barkby Group Plc, commented:

 

"We are extremely excited by the significant benefits that SleepHub™ can deliver, helping them address the root cause of poor-quality sleep and insomnia. Through the combination of science and technology we have developed an excellent product that has the potential to free individuals from sleep anxiety and the side effects of sleep deprivation, which can lead to a range of physical and mental health issues."

 

 

Enquiries:

 

The Barkby Group PLC

 

Charles Dickson, Executive Chairman

Douglas Benzie, Chief Financial Officer

 

 

 

 

finnCap Ltd (Nomad and Broker)

+44 (0) 20 7220 0500

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)

 

 

Camarco (Financial PR)

+44 (0) 20 3757 4994

Jennifer Renwick/Jake Thomas

 

 

Notes to editors

About SleepHub™:

SleepHub™ is designed to help restore natural sleep cycles and improves wellbeing. It has four modes scientifically designed to act as a natural sleep aid by using rhythms and pulses to emulate brain waves produced during sleep.

The four modes guide the consumer through a series of sleep cycles to support them throughout the night and imitate the brain's natural sleep patterns. A variety of soundscapes complement each mode, enabling the brain to relax and find its natural sleep pattern. These sounds enable the brain to re-train and revert to those natural sleep cycles and help the consumer feel reinvigorated. 

 

About The Barkby Group Plc:

The Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses within Barkby include; Commercial Property Development, Barkby Hospitality (comprising Barkby Pubs and Workshop Coffee) and Centurian Automotive.

In addition to these businesses, Barkby Life Sciences has invested in VivoPlex, a digital health company aiming to transform Women's Health with precision medicine, and it has signed an agreement with Cambridge Sound Technologies UK Ltd for the exclusive design of, and acquisition of the intellectual property rights related to, a device to improve and facilitate natural sleep

Barkby's strategy is to accelerate and maximise opportunities within its existing businesses as well as continue to source and invest in cash generative, growth businesses with the ability to disrupt.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQLLFLBBLLFBX
12
Date   Source Headline
30th Jan 20246:03 pmRNSChange of Name to Roadside Real Estate plc
2nd Jan 20247:00 amRNSResult of General Meeting
19th Dec 202311:15 amRNSUpdate on debt refinancing and CSS
15th Dec 20237:00 amRNSFirst joint venture acquisition
13th Dec 20235:39 pmRNSPosting of Circular and Notice of General Meeting
4th Dec 20237:00 amRNSIntention to refinance debt facilities
7th Nov 20237:00 amRNSPractical completion of second Roadside asset
31st Oct 20237:00 amRNSFormation of Roadside Real Estate Joint Venture
29th Sep 20237:00 amRNSTrading update
19th Sep 20237:00 amRNSCSS Announces Licensing Deal with Mammoth
11th Sep 20237:00 amRNSResponse to media speculation re CSS
1st Aug 20237:00 amRNSDisposal of Workshop Coffee
14th Jun 20237:42 amRNSCSS announces new licensing agreement
9th Jun 20237:00 amRNSPub portfolio update
6th Jun 20237:00 amRNSMajor licensing deal for Cambridge Sleep Sciences
31st May 20237:00 amRNSPractical completion of first Roadside asset
15th May 20237:00 amRNSBoard Update, Equity Issue & Total Voting Rights
31st Mar 20237:00 amRNSInterim results
22nd Feb 20235:26 pmRNSResult of AGM
16th Jan 20237:00 amRNSNotice of AGM & Debt Facility Drawing
30th Dec 20227:01 amRNSFinal results for the year ended 2 July 2022
30th Dec 20227:00 amRNSRevised debt facility
28th Nov 20227:00 amRNSTrading and Strategy Update
25th Nov 20227:00 amRNSAcquisition of the Eliot Arms
7th Sep 20225:48 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSTrading and Strategy Update
21st Jun 20223:19 pmRNSDirector/PDMR Shareholding
11th May 20225:21 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSExchange of Contracts at Saffron Walden, Essex
1st Apr 20227:00 amRNSAcquisition of The Coach and Horses
30th Mar 20227:20 amRNSInterim Results
4th Mar 20226:09 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSAppointment of Group Property Director
2nd Mar 20227:00 amRNSVerso Biosense completes clinical study
1st Mar 20227:00 amRNSBoard Update
8th Feb 20225:35 pmRNSResult of AGM
3rd Feb 20223:33 pmRNSIssue of Equity and Total Voting Rights
25th Jan 20227:00 amRNSCambridge Sleep Sciences Announces New Partners
18th Jan 20227:00 amRNSVerso Biosense study nears completion
13th Jan 20227:00 amRNSPosting of Annual Report & Notice of AGM
24th Dec 20217:00 amRNSFinal Results for the Year Ended 1 July 2021
20th Dec 20212:06 pmRNSSecond Price Monitoring Extn
20th Dec 20212:00 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSExchange of Contracts in Swindon, Wiltshire
27th Oct 20214:41 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Oct 20212:05 pmRNSSecond Price Monitoring Extn
27th Oct 20212:00 pmRNSPrice Monitoring Extension
27th Oct 202111:05 amRNSSecond Price Monitoring Extn
27th Oct 202111:00 amRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.